| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |



From the Division of Genetics of the Department of
Morphology,*
the Division of Medical Pathology of the
Department of Pathology,
and the Division of
Pediatric Surgery of the Department of
Surgery,
Universidade Federal de São
Paulo, Escola Paulista de Medicina, São Paulo; the Instituto de
Oncologia Pediátrica,§
Universidade
Federal de São Paulo, Escola Paulista de Medicina, São
Paulo; and the Division of Pediatric Oncology,¶
Hospital Servidor Público Estadual, São Paulo, Brazil
Neuroblastoma is the second most common solid tumor occurring in children. Amplification of the MYCN oncogene is associated with poor prognosis. To identify neuroblastoma tumors with MYCN amplification, we studied the number of copies of MYCN in interphase cells by fluorescence in situ hybridization in 20 neuroblastoma patients. MYCN amplification appeared in 7 tumor specimens. Interphase and metaphase studies showed a tumor cell population with both forms of amplification, double minutes and homogeneously staining regions, in two patients. These patients showed a smaller tumor cell subpopulation with the presence of more than one homogeneously staining region, suggesting that gene amplification was undergoing karyotype evolution.
This article has been cited by other articles:
![]() |
A. Weber, S. Starke, E. Bergmann, and H. Christiansen The Coamplification Pattern of the MYCN Amplicon Is an Invariable Attribute of Most MYCN-Amplified Human Neuroblastomas Clin. Cancer Res., December 15, 2006; 12(24): 7316 - 7321. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Moreau, P. McGrady, W. B. London, H. Shimada, S. L. Cohn, J. M. Maris, L. Diller, A. T. Look, and R. E. George Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study. Clin. Cancer Res., October 1, 2006; 12(19): 5693 - 5697. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |